Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2016-03-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immediate Skin-to-skin Contact After C-section
NCT01862432
Pilot Study: Sectio Bonding/Early Skin-to-skin Contact (SSC) After Caesarean Section
NCT01894880
Impact of Skin to Skin Contact on Maternal Satisfaction, Pain Scores, and Narcotic Usage After Cesarean Delivery
NCT02533167
Interventions That Promote Exclusive Breastfeeding
NCT04052984
Incidence and Prevention of Hypothermia in Newborns Bonding During Caesarean Section
NCT01793558
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
immediate mother-skin-to-skin contact(SSC)
The immediate mother-SSC begins directly after birth (still during the C-section)
Skin-to-skin contact
immediate father-SSC
The immediate father-SSC begins directly after birth (still during C-section)
Skin-to-skin contact
Routine care;mother-SSC after 30 minutes
After birth (still during C-section) the newborn gets routine care of a midwife close to the mother. SSC with mother after 30 minutes
Skin-to-skin contact
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Skin-to-skin contact
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* severe diseases
* drug abuse
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johann Wolfgang Goethe University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Silvia Oddo
Dr.rer.nat.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Louwen, Prof.
Role: STUDY_DIRECTOR
University Hospital Frankfurt-Dept. Obstetrics and Perinatal Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Frankfurt-Dept.Obstetrics and Perinatal Medicine
Frankfurt am Main, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E 9/15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.